Clinical Trials
14
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials
Immunotherapy in Lung Cancer: Treatment After IO Cessation.
- Conditions
- Carcinoma, Non-Small-Cell LungImmunotherapy
- First Posted Date
- 2020-07-10
- Last Posted Date
- 2021-08-23
- Lead Sponsor
- European Lung Cancer Working Party
- Target Recruit Count
- 300
- Registration Number
- NCT04465942
- Locations
- 🇧🇪
Department of Intensive Care Unit and Thoracic Oncology Institut Jules Bordet, Brussels, Belgium
🇧🇪Department of Pneumology CHU Charleroi, Charleroi, Belgium
🇧🇪Department of Pneumology Hôpital Saint-Joseph, Gilly, Belgium
Cardiovascular Morbidities and Lung Cancer Treatment: a Prospective Registry
- Conditions
- Lung Neoplasm
- First Posted Date
- 2017-12-11
- Last Posted Date
- 2021-08-23
- Lead Sponsor
- European Lung Cancer Working Party
- Target Recruit Count
- 200
- Registration Number
- NCT03368820
- Locations
- 🇧🇪
Department of Intensive Care Unit and Thoracic Oncology Institut Jules Bordet, Brussels, Belgium
🇧🇪Hôpital Saint-Joseph, Charleroi, Belgium
🇧🇪CHU Tivoli, La Louvière, Belgium
Has Inflammation a Significant Implication in Lung Cancer Evolution?
- Conditions
- Lung Neoplasms
- First Posted Date
- 2015-06-30
- Last Posted Date
- 2021-08-23
- Lead Sponsor
- European Lung Cancer Working Party
- Target Recruit Count
- 400
- Registration Number
- NCT02484872
- Locations
- 🇧🇪
Department of Intensive Care Unit and Thoracic Oncology Institut Jules Bordet, Brussels, Belgium
Bronchoscopy Assisted by Electromagnetic Navigation (EMN) in the Diagnosis of Small Pulmonary Nodules
- Conditions
- Pulmonary Nodule Cm
- First Posted Date
- 2013-01-30
- Last Posted Date
- 2022-04-04
- Lead Sponsor
- European Lung Cancer Working Party
- Target Recruit Count
- 120
- Registration Number
- NCT01779388
- Locations
- 🇧🇪
Institut Jules Bordet, Brussels, Belgium
Biological Factors Predicting Response to Chemotherapy in Advanced Non Small Cell Lung Cancer
- Conditions
- Non Small Cell Lung Carcinoma
- Interventions
- Drug: Chemotherapy
- First Posted Date
- 2009-03-18
- Last Posted Date
- 2020-06-26
- Lead Sponsor
- European Lung Cancer Working Party
- Target Recruit Count
- 70
- Registration Number
- NCT00864266
- Locations
- 🇧🇪
Department of Pneumology Clinique Saint-Luc, Bouge, Belgium
🇧🇪Department of Intensive Care Unit and Thoracic Oncology Institut Jules Bordet, Brussels, Belgium
🇧🇪Service de Pneumologie Hôpital Erasme, Brussels, Belgium
- Prev
- 1
- 2
- 3
- Next